Journal Watch · Science Advances · 2026

SIRT2 antagonizes MOF function during mitotic entry.

Our findings reveal a previously unrecognized layer of regulation in G<sub>2</sub>-M progression with possible impact in cancer, highlighting the intricate cross-talk between chromatin dynamics and mitotic control and providing important insights into chromosomal stability.

Espinosa-Alcantud M, Sima N, Fernández-Duran I et al.Science Advances3 min readPharma relevance 40/100

DOI: 10.1126/sciadv.aeb2915PMID: 42319919Study type: research study

TL;DR

Our findings reveal a previously unrecognized layer of regulation in G<sub>2</sub>-M progression with possible impact in cancer, highlighting the intricate cross-talk between chromatin dynamics and mitotic control and providing important insights into chromosomal stability.

Key findings

  • Our findings reveal a previously unrecognized layer of regulation in G<sub>2</sub>-M progression with possible impact in cancer, highlighting the intricate cross-talk between chromatin dynamics and mitotic control and providing important insights into chromosomal stability.

What they did

Here, we identify a functional antagonism between the deacetylase SIRT2 and the acetyltransferase MOF in the G<sub>2</sub>-M transition and mitotic progression. This interplay, which involves MOF deacetylation by SIRT2, regulates key histone marks, including H4K16ac (histone 4 lysine-16 acetylation) deacetylation and H4K20me1 (histone 4 lysine-20 monomethylation) deposition, condensin II loading, and the stability of the key mitotic regulator PLK1, and contributes to the FOXM1-mediated transcriptional control of mitosis.

Full abstract (original)

Background: Mitosis entry is tightly regulated by a complex network of mechanisms involving epigenetic modifications, signaling pathways, transcriptional control, and structural changes. Although substantial progress has been made in understanding these processes individually, the mechanisms integrating chromatin dynamics with mitotic regulators are still not fully understood.

What they did: Here, we identify a functional antagonism between the deacetylase SIRT2 and the acetyltransferase MOF in the G<sub>2</sub>-M transition and mitotic progression. This interplay, which involves MOF deacetylation by SIRT2, regulates key histone marks, including H4K16ac (histone 4 lysine-16 acetylation) deacetylation and H4K20me1 (histone 4 lysine-20 monomethylation) deposition, condensin II loading, and the stability of the key mitotic regulator PLK1, and contributes to the FOXM1-mediated transcriptional control of mitosis.

Results & conclusions: Our findings reveal a previously unrecognized layer of regulation in G<sub>2</sub>-M progression with possible impact in cancer, highlighting the intricate cross-talk between chromatin dynamics and mitotic control and providing important insights into chromosomal stability.

Abstract © the authors / Science Advances (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1126/sciadv.aeb2915 · PubMed 42319919.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Science Advances for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Science Advances study find?

Our findings reveal a previously unrecognized layer of regulation in G<sub>2</sub>-M progression with possible impact in cancer, highlighting the intricate cross-talk between chromatin dynamics and mitotic control and providing important insights into chromosomal stability.

What type of study is this?

It is a research study, published in Science Advances in 2026. Here, we identify a functional antagonism between the deacetylase SIRT2 and the acetyltransferase MOF in the G<sub>2</sub>-M transition and mitotic progression.

Where can I read the original paper?

The original is at the publisher via DOI 10.1126/sciadv.aeb2915. PubMed ID: 42319919. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Espinosa-Alcantud M, Sima N, Fernández-Duran I et al.. SIRT2 antagonizes MOF function during mitotic entry.. Science Advances (2026). DOI: 10.1126/sciadv.aeb2915.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/sirt2-antagonizes-mof-function-during-mitotic-entry-eb2915/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides